Avricore Health Inc.
CIK 1355736fmd_11QFD1GR3V20V7JS42ST0QDP7XManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2014 to Dec 31, 2025, 16 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 0 | 2 | 3 | 5 |
| Cost of revenue | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 |
| Gross profit | 0 | 0 | (0) | 0 | 0 | 0 | 0 | 1 | 2 |
| Research and development | 0 | 0 | 0 | – | – | – | – | – | – |
| Selling, general and administrative | 2 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – |
| Income before taxes | – | – | – | – | – | (2) | (1) | (1) | 0 |
| Net income from continuing operations | – | (1) | (3) | (2) | (0) | 0 | (0) | – | – |
| Net income | (3) | (1) | (3) | (2) | (1) | (2) | (1) | (1) | (1) |